Literature DB >> 22212963

Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008.

Ju Dong Yang1, Bohyun Kim, Schuyler O Sanderson, Jennifer L St Sauver, Barbara P Yawn, Rachel A Pedersen, Joseph J Larson, Terry M Therneau, Lewis R Roberts, W Ray Kim.   

Abstract

OBJECTIVE: To analyze longitudinal trends in the incidence, etiology, and treatment of hepatocellular carcinoma (HCC) in community residents in Olmsted County, Minnesota, and their survival. PATIENTS AND METHODS: Olmsted County residents 20 years or older with HCC newly diagnosed from January 1, 1976, through December 31, 2008, were identified using a community-wide medical record linkage system (Rochester Epidemiology Project). The incidence rate of HCC was calculated by age and sex according to the 2000 US Census population. Temporal trends of HCC etiology, treatment, and patient survival were assessed.
RESULTS: The age- and sex-adjusted incidence rate for HCC in Olmsted County was 3.5 per 100,000 person-years for the first era (1976-1990), 3.8 per 100,000 for the second era (1991-2000), and 6.9 per 100,000 for the third era (2001-2008). Alcohol use was the most common risk factor in the first and second eras and chronic hepatitis C virus in the third. The proportion attributed to nonalcoholic fatty liver disease was small (5/47 [10.6%] in the third era). Because the proportion of patients receiving curative treatment increased over time, survival also improved, with a median survival time of 3, 6, and 9 months in the first, second, and third eras, respectively (P=.01).
CONCLUSION: In this midwestern US community, the incidence of HCC has increased, primarily due to hepatitis C virus. Although there was a demonstrable improvement in the outcome of HCC in community residents over time, the overall prognosis remains poor.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22212963      PMCID: PMC3538386          DOI: 10.1016/j.mayocp.2011.07.001

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  27 in total

1.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

2.  Factors that affect risk for hepatocellular carcinoma and effects of surveillance.

Authors:  Ju Dong Yang; William S Harmsen; Seth W Slettedahl; Roongruedee Chaiteerakij; Felicity T Enders; Terry M Therneau; Lucinda Orsini; W Ray Kim; Lewis R Roberts
Journal:  Clin Gastroenterol Hepatol       Date:  2011-04-01       Impact factor: 11.382

Review 3.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.

Authors:  Josep M Llovet; Maria Isabel Real; Xavier Montaña; Ramon Planas; Susana Coll; John Aponte; Carmen Ayuso; Margarita Sala; Jordi Muchart; Ricard Solà; Joan Rodés; Jordi Bruix
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

5.  Risk factors for the rising rates of primary liver cancer in the United States.

Authors:  H B El-Serag; A C Mason
Journal:  Arch Intern Med       Date:  2000-11-27

6.  Diagnosis and 10-year follow-up of a community-based hepatitis C cohort.

Authors:  Barbara P Yawn; Peter Wollan; Liliana Gazzuola; W Ray Kim
Journal:  J Fam Pract       Date:  2002-02       Impact factor: 0.493

7.  Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women.

Authors:  F Donato; A Tagger; U Gelatti; G Parrinello; P Boffetta; A Albertini; A Decarli; P Trevisi; M L Ribero; C Martelli; S Porru; G Nardi
Journal:  Am J Epidemiol       Date:  2002-02-15       Impact factor: 4.897

8.  NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Authors:  Jorge A Marrero; Robert J Fontana; Grace L Su; Hari S Conjeevaram; Dawn M Emick; Anna S Lok
Journal:  Hepatology       Date:  2002-12       Impact factor: 17.425

9.  The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.

Authors:  Hashem B El-Serag; Jessica A Davila; Nancy J Petersen; Katherine A McGlynn
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

10.  Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States.

Authors:  Manal M Hassan; Adam Frome; Yehuda Z Patt; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2002-09       Impact factor: 3.062

View more
  22 in total

1.  Hepatitis C virus infection and the rising incidence of hepatocellular carcinoma.

Authors:  Denise M Harnois
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

2.  Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

Authors:  Ju Dong Yang; Manal F Abdelmalek; Herbert Pang; Cynthia D Guy; Alastair D Smith; Anna Mae Diehl; Ayako Suzuki
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

3.  Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma.

Authors:  Scott M Thompson; Danielle E Jondal; Kim A Butters; Bruce E Knudsen; Jill L Anderson; Matthew P Stokes; Xiaoying Jia; Joseph P Grande; Lewis R Roberts; Matthew R Callstrom; David A Woodrum
Journal:  Int J Hyperthermia       Date:  2017-11-06       Impact factor: 3.914

4.  Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study.

Authors:  Ju Dong Yang; Hager Ahmed Mohammed; William S Harmsen; Felicity Enders; Gregory J Gores; Lewis R Roberts
Journal:  J Clin Gastroenterol       Date:  2017-09       Impact factor: 3.062

5.  Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.

Authors:  Yukihito Ishii; Yu Motohashi; Makoto Muramatsu; Yoshiaki Katsuda; Katsuhiro Miyajima; Tomohiko Sasase; Takahisa Yamada; Tohru Matsui; Shinichi Kume; Takeshi Ohta
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

6.  The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.

Authors:  Alina M Allen; Stephen B Hicks; Kristin C Mara; Joseph J Larson; Terry M Therneau
Journal:  J Hepatol       Date:  2019-08-27       Impact factor: 25.083

7.  Recurrent hepatocellular carcinoma: it's the virus!

Authors:  W Ray Kim; Gregory J Gores
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

8.  Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.

Authors:  Ju Dong Yang; Joseph J Larson; Kymberly D Watt; Alina M Allen; Russell H Wiesner; Gregory J Gores; Lewis R Roberts; Julie A Heimbach; Michael D Leise
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-21       Impact factor: 11.382

9.  Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI.

Authors:  Scott M Thompson; Ishan Garg; Eric C Ehman; Shannon P Sheedy; Candice A Bookwalter; Rickey E Carter; Lewis R Roberts; Sudhakar K Venkatesh
Journal:  Br J Radiol       Date:  2018-08-29       Impact factor: 3.039

10.  Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.

Authors:  Ju Dong Yang; Hager Amed Mohamed; Jessica L Cvinar; Gregory J Gores; Lewis R Roberts; W Ray Kim
Journal:  Am J Gastroenterol       Date:  2016-08-16       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.